Scleroderma prevalence: Demographic variations in a population-based sample

Arthritis Care and Research

Volumn 61, Issue 3, 2009, Pages 400-404

  Bernatsky, S ^a,c   Joseph, L ^a   Pineau, C A ^a   Belisle, P ^a   Hudson, M ^b   Clarke, A E ^a  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; ALGORITHM; ARTICLE; BAYES THEOREM; COMPARATIVE STUDY; DATA BASE; DEMOGRAPHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION; PREVALENCE; RURAL AREA; SCLERODERMA; SENSITIVITY ANALYSIS; SEX; STATISTICAL ANALYSIS; SYSTEMIC SCLEROSIS;

ADULT; AGE DISTRIBUTION; ALGORITHMS; BAYES THEOREM; DATABASES, FACTUAL; FEMALE; HOSPITALIZATION; HUMANS; INTERNATIONAL CLASSIFICATION OF DISEASES; MALE; MIDDLE AGED; PREVALENCE; QUEBEC; SCLERODERMA, LOCALIZED; SCLERODERMA, SYSTEMIC; SEX DISTRIBUTION;

EID: 62549165425     PISSN: 21514658     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.24339     Document Type: Article

References (16)

1. Chifflot H, Fautrel B, Sordet C, Chatelus E, Sibilia J. Incidence and prevalence of systemic sclerosis: a systematic literature review. Semin Arthritis Rheum 2008;37:223-35.
2. Michet CJ, McKenna CH, Elveback LR, Kaslow RA, Kurland LT. Epidemiology of systemic lupus-erythematosus and other connective-tissue diseases in Rochester, Minnesota, 1950 through 1979. Mayo Clin Proc 1985;60:105-13.
3. Maricq HR, Weinrich MC, Keil JE, Smith EA, Harper FE, Nussbaum AI, et al. Prevalence of scleroderma spectrum disorders in the general population of South Carolina. Arthritis Rheum 1989;32:998-1006.
4. Steen VD, Oddis CV, Conte CG, Janoski J, Casterline GZ, Medsger TA Jr. Incidence of systemic sclerosis in Allegheny County, Pennsylvania: a twenty-year study of hospital- diagnosed cases, 1963-1982. Arthritis Rheum 1997;40:441-5.
5. Mayes MD, Lacey JV Jr, Beebe-Dimmer J, Gillespie BW, Cooper B, Laing TJ, et al. Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population. Arthritis Rheum 2003;48:2246-55.
6. Medsger TA, Masi AT, Rodnan GP, Benedek TG, Robinson H. Survival with systemic sclerosis (scleroderma): life-table analysis of clinical and demographic factors in 309 patients. Ann Intern Med 1971;75:369-76.
7. Medsger TA Jr, Masi AT. The epidemiology of systemic sclerosis (scleroderma) among male U.S. veterans. J Chronic Dis 1978;31:73-85.
8. Kurland LT, Hauser WA, Ferguson RH, Holley KE. Epidemiologic features of diffuse connective tissue disorders in Rochester, Minn, 1951 through 1967, with special reference to systemic lupus erythematosus. Mayo Clin Proc 1969;44: 649-63.
9. Ladouceur M, Rahme E, Pineau CA, Joseph L. Robustness of prevalence estimates derived from misclassified data from administrative databases. Biometrics 2007;63:272-9.
10. Wilchesky M, Tamblyn RM, Huang A. Validation of diagnostic codes within medical services claims. J Clin Epidemiol 2004;57:131-41.
11. Ashby D. Bayesian statistics in medicine: a 25 year review. Stat Med 2006;25:3589-631.
12. Bernatsky S, Joseph L, Pineau CA, Tamblyn R, Feldman DE, Clarke AE. A population-based assessment of systemic lupus erythematosus incidence and prevalence: results and implications of using administrative data for epidemiological studies. Rheumatology (Oxford) 2007;46:1814-8.
13. Ferri C, Valentini G, Cozzi F, Sebastiani M, Michelassi C, la Montagna G, et al. Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients. Medicine (Baltimore) 2002;81:139-53.
14. Lonzetti LS, Joyal F, Raynauld JP, Roussin A, Goulet JR, Rich E, et al. Updating the American College of Rheumatology preliminary classification criteria for systemic sclerosis: addition of severe nailfold capillaroscopy abnormalities markedly increases the sensitivity for limited scleroderma [letter]. Arthritis Rheum 2001;44:735-6.
15. Giordano M, Valentini G, Migliaresi S, Picillo U, Vatti M. Different antibody patterns and different prognoses in patients with scleroderma with various extent of skin sclerosis. J Rheumatol 1986;13:911-6.
16. Alamanos Y, Tsifetaki N, Voulgari PV, Siozos C, Tsamandouraki K, Alexiou GA, et al. Epidemiology of systemic sclerosis in northwest Greece 1981 to 2002. Semin Arthritis Rheum 2005;34:714-20.